StemGen, Inc. announced earnings results for the full year ended June 30, 2021. For the full year, the company announced sales was USD 16,000 compared to USD 4,000 a year ago. Sales was USD 16,000 compared to USD 15,350 a year ago. Sales was USD 23,000 compared to USD 4,000 a year ago. Sales was USD 23,000 compared to USD 15,350 a year ago. Operating loss was USD 243,924 compared to USD 67,070 a year ago. Net loss was USD 433,143 compared to USD 230,772 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.